Daily Voice: Anil Rego cautious on US-exposed pharma stocks; warns against underestimating tariff-led global slowdown

From an investment perspective, Anil Rego, Founder and Fund Manager at Right Horizons PMS, said he would be cautious on high US-exposure names like Aurobindo Pharma, after Trump's tariff on branded and patented pharma drugs.
Read more...